Pu Li-jun, Huang Song-min, Liu Fei
Department of Nephrology, West China Hospital, Sichuan University, Chengdu 610041, China.
Sichuan Da Xue Xue Bao Yi Xue Ban. 2007 Sep;38(5):813-5.
To investigate the effects of high glucose on expressions of plasminogen activator (PA) and plasminogen activator inhibitor-1 (PAI-1) of rat proximal tubular epithelial cells, and the role of angiotensin II receptor antagonist Losartan.
The cultured NRK-52E cells (a renal proximal tubular epithelial cell line of rat origin) were divided into five groups: control group, mannitol group (5 mmol/L D-glucose plus 25 mmol/L mannitol), high glucose group (30 mmol/L D-glucose), losartan group (10(-3) mmol/L losartan), high glucose plus losartan group (30 mmol/L D-glucose plus 10(-3) mmol/L losartan). Semi-quantity RT-PCR was used to detect the expression of PA/PAI-1 mRNA.
Compared with control group, the high glucose group decreased the expressions of tissue plasminogen activator (tPA) and urokinase plasminogen activator (uPA) mRNAs (P < 0.01) and increased PAI-1 mRNA expression (P < 0.01) in cultured NRK-52E cells. Losartan could reverse partly the expression of PA/PAI-1 mRNA. Compared to high glucose group, the PA mRNA expression was significantly increased (P < 0.01) and the PAI-1 mRNA expression was decreased greatly (P < 0.01) to high glucose plus losartan group.
The abnormal expression of PA/PAI-1 mRNA may play an important role in the accumulation of extracellular matrix (ECM) of diabetic nephropathy (DN). Losartan may keep the balance of PA/PAI-1 and have a protective effect on DN.
探讨高糖对大鼠近端肾小管上皮细胞纤溶酶原激活物(PA)及纤溶酶原激活物抑制剂-1(PAI-1)表达的影响,以及血管紧张素Ⅱ受体拮抗剂氯沙坦的作用。
将培养的NRK-52E细胞(大鼠源性肾近端肾小管上皮细胞系)分为五组:对照组、甘露醇组(5 mmol/L D-葡萄糖加25 mmol/L甘露醇)、高糖组(30 mmol/L D-葡萄糖)、氯沙坦组(10⁻³ mmol/L氯沙坦)、高糖加氯沙坦组(30 mmol/L D-葡萄糖加10⁻³ mmol/L氯沙坦)。采用半定量RT-PCR检测PA/PAI-1 mRNA的表达。
与对照组相比,高糖组培养的NRK-52E细胞中组织型纤溶酶原激活物(tPA)和尿激酶型纤溶酶原激活物(uPA)mRNA表达降低(P < 0.01),PAI-1 mRNA表达增加(P < 0.01)。氯沙坦可部分逆转PA/PAI-1 mRNA的表达。与高糖组相比,高糖加氯沙坦组PA mRNA表达显著增加(P < 0.01),PAI-1 mRNA表达显著降低(P < 0.01)。
PA/PAI-1 mRNA的异常表达可能在糖尿病肾病(DN)细胞外基质(ECM)积聚中起重要作用。氯沙坦可能维持PA/PAI-1的平衡,对DN具有保护作用。